<code id='990C3EBF4B'></code><style id='990C3EBF4B'></style>
    • <acronym id='990C3EBF4B'></acronym>
      <center id='990C3EBF4B'><center id='990C3EBF4B'><tfoot id='990C3EBF4B'></tfoot></center><abbr id='990C3EBF4B'><dir id='990C3EBF4B'><tfoot id='990C3EBF4B'></tfoot><noframes id='990C3EBF4B'>

    • <optgroup id='990C3EBF4B'><strike id='990C3EBF4B'><sup id='990C3EBF4B'></sup></strike><code id='990C3EBF4B'></code></optgroup>
        1. <b id='990C3EBF4B'><label id='990C3EBF4B'><select id='990C3EBF4B'><dt id='990C3EBF4B'><span id='990C3EBF4B'></span></dt></select></label></b><u id='990C3EBF4B'></u>
          <i id='990C3EBF4B'><strike id='990C3EBF4B'><tt id='990C3EBF4B'><pre id='990C3EBF4B'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:66654
          Novo Nordisk Denmark
          LISELOTTE SABROE/AFP/Getty Images

          A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

          In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

          advertisement

          Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Medical schools are missing the mark on artificial intelligence
          Medical schools are missing the mark on artificial intelligence

          GUILLAUMESOUVANT/AFPviaGettyImagesReadyornot,healthcareisundergoingamassivetransformationdrivenbyart

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Hubble vs. James Webb telescope images: See the difference

          2:22NASA'sJamesWebbSpaceTelescoperevealsStephan'sQuintetinanewlight.Avisualgroupingoffivegalaxies,is